Hôpital Robert-Debré

Running trials

• Not yet recruiting

  Verapamil In Preclinical Type 1 Diabetes

  NCT07880769· Phase 2/3· Source

• Not yet recruiting

  GENES AND AUTISM - Induced Pluripotent Stem Cells

  NCT07311213· Source

• Not yet recruiting

  Epidemiology of Invasive Bacterial Infections in Children With Sickle Cell Disease in France Between 2020 and 2025

  NCT07639008· Source

• Not yet recruiting

  Denys-Drash Syndrome and Risk of Post-transplant Lymphoproliferative Disorder

  NCT07605884· Source

• Not yet recruiting

  Exploring the Physiological Mechanisms of Austism Through Organoids

  NCT07494331· Source

• Recruiting

  Study of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic Leukemia

  NCT07483476· Source

• Recruiting

  The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France

  NCT07211126· Source

• Recruiting

  Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents

  NCT05126914· Source

• Not yet recruiting

  Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

  NCT06798532· Source

• Recruiting

  Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation

  NCT07251673· Source

• Not yet recruiting

  Open Label Phase IIa Trial Evaluating the Effect and Safety of Transplantation of Fecal Microbiota in Children With Autism Spectrum Disorders and Gastrointestinal Symptoms

  NCT07105267· Phase 2· Source

• Recruiting

  Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms

  NCT06508931· Phase 2· Source

• Active, not recruiting

  A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

  NCT06872125· Phase 3· Source

• Recruiting

  Evaluation of a Therapeutic Education Program for Pregnant Women With a First Child Diagnosed With an Autism Spectrum Disorder

  NCT05104112· Source

• Recruiting

  Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data

  NCT06380192· Source

• Recruiting

  IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

  NCT06112314· Phase 3· Source

• Recruiting

  Efficacy of Automated Insulin Therapy Early Initiated After Diagnosis on Blood Glucose Control in Children and Adolescents With Type 1 Diabetes

  NCT06283797· Source

• Recruiting

  Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation

  NCT05983991· Source

• Recruiting

  Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies

  NCT05772559· Source

• Recruiting

  The Patient Cohort of the National Center for Precision Medicine in Leukemia

  NCT05326919· Source

• Recruiting

  Phenotypic Exploration of Autism Spectrum Disorders Retrospective and Prospective Data

  NCT04923854· Source

• Recruiting

  Study of the Genetic Factors Involved in Autism and Related Disorders

  NCT04727489· Source

• Recruiting

  Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

  NCT04356326· Phase 3· Source

• Recruiting

  A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

  NCT04901936· Phase 2· Source

• Recruiting

  Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults

  NCT04477681· Source

• Recruiting

  Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

  NCT03934372· Phase 1/2· Source

• Recruiting

  Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

  NCT04832607· Phase 3· Source

• Recruiting

  Natural History Study of Usher Syndrome ( Light4Deaf )

  NCT04665726· Source

• Recruiting

  IDMet (RaDiCo Cohort) (RaDiCo-IDMet)

  NCT05945576· Source

• Active, not recruiting

  A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents

  NCT02716233· Phase 3· Source

• Enrolling by invitation

  Juvenile Inflammatory Rheumatism (JIR) Cohorte

  NCT02377245· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers7 recruiting
• Autism6 recruiting
• Acute myeloid leukemia4 recruiting
• Acute lymphoblastic leukaemia3 recruiting
• Epilepsy3 recruiting
• Type 1 diabetes3 recruiting
• Myelodysplastic syndromes2 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• High blood pressure1 recruiting
• Melanoma1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Neuroblastoma1 recruiting
• Rheumatoid arthritis1 recruiting
• Sickle cell disease1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Avoidant and Restrictive Food Intake Disorders (ARFID) in Adolescence: Early Oral Development, Psychopathological Profile and Sensory Integration

  NCT06665802· Source

• Completed

  Perinatal Thoraco-abdomino-pelvic Tumors Study

  NCT06365268· Source

• Completed

  COVID-19 Antibody Responses in Cystic Fibrosis

  NCT05614336· Source

• Terminated

  A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome

  NCT05163314· Phase 3· Source

• Completed

  Effect of Lithium in Patients With Autism Spectrum Disorder and Phelan-McDermid Syndrome (SHANK3 Haploinsufficiency)

  NCT04623398· Phase 3· Source

• Completed

  A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome

  NCT04938427· Phase 3· Source

• Completed

  A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome

  NCT04940624· Phase 3· Source

• Completed

  A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation

  NCT05076149· Phase 3· Source

• Completed

  Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings

  NCT04969601· Phase 1/2· Source

• Terminated

  A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

  NCT04501614· Phase 1/2· Source

• Completed

  Home Airway Clearance in CF Patients

  NCT04096664· Source

• Completed

  HLA Haploidentical Bone Marrow Transplant in Patients With Severe Sickle Cell Disease

  NCT03240731· Phase 2· Source

• Completed

  Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

  NCT02625480· Phase 1/2· Source

• Completed

  French Registry of First-line Treatment of Acute Promyelocytic Leukemia

  NCT02938858· Source

• Completed

  Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

  NCT02303821· Phase 1· Source

Trial sites

• CHU Robert Debré3 trials
• CHU Robert Débré, AP-HP1 trial
• Department of Pediatric Gastroenterology, Robert Debré Hospital0 trials
• Hopital Robert Debre30 trials
• Hôpital Robert Debré, APHP1 trial
• Hopital Robert Debré - Neurologie1 trial
• Hôpital Robert Debré - Paris1 trial
• Hopital Robert Debre - Pulmonology0 trials
• Hôpital Robert Debré - Service d'hémato-immunologie0 trials
• Hopital Robert Debre - Sevice d'Hemato-immunologic1 trial
• Hospital Robert-Debré1 trial
• Robert Debre hospital4 trials
• Robert Debré Hospital, AP-HP1 trial
• Robert-Debré Hospital Paris1 trial
• Hopital Robert Debre1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Acute lymphoblastic leukaemia28 works · 8 trials
• Sickle cell disease11 works · 2 trials